Actos and Roxicet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actos (pioglitazone hydrochloride) and Roxicet (acetaminophen; oxycodone hydrochloride). Common drug interactions include abdominal pain among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Actos and Roxicet. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.

What is Roxicet?

Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

17 people who take Actos and Roxicet together, and have interactions are studied.

Actos and Roxicet drug interactions.

What are the common drug interactions of Actos and Roxicet, by gender? *:

female:

  1. Abdominal pain
  2. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  3. Chronic kidney disease
  4. Diarrhoea
  5. Headache (pain in head)
  6. Pancreatitis (inflammation of pancreas)
  7. Renal failure (kidney dysfunction)
  8. Renal injury (kidney injury)
  9. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Decreased appetite
  4. Fall
  5. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  6. International normalised ratio increased
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Nausea (feeling of having an urge to vomit)
  9. Oedema (fluid collection in tissue)
  10. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)

What are the common drug interactions of Actos and Roxicet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  3. Diarrhoea
  4. Headache (pain in head)
  5. Pancreatitis (inflammation of pancreas)
  6. Renal injury (kidney injury)
  7. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Weight increased

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema (fluid collection in tissue)
  5. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  6. Prostate cancer
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Vomiting
  9. Weight decreased
  10. Weight increased

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 35.29%
  2. Infection: 5 people, 29.41%
  3. High Blood Cholesterol: 5 people, 29.41%
  4. Indigestion: 5 people, 29.41%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 23.53%
  6. High Blood Pressure: 4 people, 23.53%
  7. Stress And Anxiety: 3 people, 17.65%
  8. General Physical Health Deterioration (weak health status): 3 people, 17.65%
  9. Neuralgia (pain in one or more nerves): 3 people, 17.65%
  10. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Actos and Roxicet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actos and Roxicet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxicet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actos and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride and acetaminophen; oxycodone hydrochloride (the active ingredients of Actos and Roxicet, respectively), and Actos and Roxicet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: